Therapy Areas: Inflammatory Diseases
20 March 2019 - - US-based biopharmaceutical company vTv Therapeutics Inc. (NASDAQ: VTVT) has entered into a definitive agreement with certain institutional investors for the purchase and sale in a re...
20 March 2019 - - US-based medical technology company Fractyl Laboratories Inc. (Fractyl) has hired Margaret Borys as chief commercial officer and Juan Carlos Lopez-Talavera, M.D., Ph.D., as chief med...
20 March 2019 - - US-based biotechnology company Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) has completed enrollment in two Phase 2 studies, the company said.

The Phase 2 study of EDP-93...
14 March 2019 - - US-based biopharmaceutical company Celgene Corp. (NASDAQ: CELG) has produced two updates for Abraxane (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) i...
14 March 2019 - The US Food and Drug Administration (FDA) has approved United States-based Regeneron Pharmaceuticals' and France-based Sanofi's Dupixent (dupilumab) for adolescent patients 1...
13 March 2019 - Biotechnology company Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi Tuesday jointly announced on Tuesday that the US Food and Drug Administration (FDA) has approved Dupixent f...